Citation: I. Tubulekas et P. Liljestrom, SUPPRESSORS OF CLEAVAGE-SITE MUTATIONS IN THE P62 ENVELOPE PROTEIN OFSEMLIKI-FOREST-VIRUS REVEAL DYNAMICS IN SPIKE STRUCTURE AND FUNCTION, Journal of virology, 72(4), 1998, pp. 2825-2831
Citation: U. Skoging et P. Liljestrom, ROLE OF THE C-TERMINAL TRYPTOPHAN RESIDUE FOR THE STRUCTURE-FUNCTION OF THE ALPHAVIRUS CAPSID PROTEIN, Journal of Molecular Biology, 279(4), 1998, pp. 865-872
Authors:
ZHANG J
ASSELINPATUREL C
BEX F
BERNARD J
CHEHIMI J
WILLEMS F
CAIGNARD A
BERGLUND P
LILJESTROM P
BURNY A
CHOUAIB S
Citation: J. Zhang et al., CLONING OF HUMAN IL-12 P40 AND P35 DNA INTO THE SEMLIKI-FOREST-VIRUS VECTOR - EXPRESSION OF IL-12 IN HUMAN TUMOR-CELLS, Gene therapy, 4(4), 1997, pp. 367-374
Authors:
BERGLUND P
QUESADAROLANDER M
PUTKONEN P
BIBERFELD G
THORSTENSSON R
LILJESTROM P
Citation: P. Berglund et al., OUTCOME OF IMMUNIZATION OF CYNOMOLGUS MONKEYS WITH RECOMBINANT SEMLIKI-FOREST-VIRUS ENCODING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PROTEIN AND CHALLENGE WITH A HIGH-DOSE OF SHIV-4 VIRUS, AIDS research and human retroviruses, 13(17), 1997, pp. 1487-1495
Authors:
MOSSMAN SP
BEX F
BERGLUND P
ARTHOS J
ONEIL SP
RILEY D
MAUL DH
BRUCK C
MOMIN P
BURNY A
FULTZ PN
MULLINS JI
LILJESTROM P
HOOVER EA
Citation: Sp. Mossman et al., PROTECTION AGAINST LETHAL SIMIAN IMMUNODEFICIENCY VIRUS SIVSMMPBJ14 DISEASE BY A RECOMBINANT SEMLIKI FOREST VIRUS GP160 VACCINE AND BY A GP120 SUBUNIT VACCINE, Journal of virology, 70(3), 1996, pp. 1953-1960
Authors:
LUNDSTROM K
MILLS A
ALLET E
CESZKOWSKI K
AGUDO G
CHOLLET A
LILJESTROM P
Citation: K. Lundstrom et al., HIGH-LEVEL EXPRESSION OF G-PROTEIN-COUPLED RECEPTORS WITH THE AID OF THE SEMLIKI-FOREST-VIRUS EXPRESSION SYSTEM, Journal of receptor and signal transduction research, 15(1-4), 1995, pp. 23-32
Authors:
BEX F
MCDOWALL A
LILJESTROM P
BURNY A
GAYNOR R
Citation: F. Bex et al., THE TAX TRANSACTIVATION PROTEIN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-ICOLOCALIZES WITH NP-KAPPAB PROTEINS IN NUCLEAR-BODIES, AIDS research and human retroviruses, 11, 1995, pp. 142-142
Authors:
ZHOU XZ
BERGLUND P
ZHAO HX
LILJESTROM P
JONDAL M
Citation: Xz. Zhou et al., GENERATION OF CYTOTOXIC AND HUMORAL IMMUNE-RESPONSES BY NONREPLICATIVE RECOMBINANT SEMLIKI-FOREST-VIRUS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(7), 1995, pp. 3009-3013
Authors:
LOEWY A
SMYTH J
VONBONSDORFF CH
LILJESTROM P
SCHLESINGER MJ
Citation: A. Loewy et al., THE 6-KILODALTON MEMBRANE-PROTEIN OF SEMLIKI FOREST VIRUS IS INVOLVEDIN THE BUDDING PROCESS, Journal of virology, 69(1), 1995, pp. 469-475
Authors:
ZHAO HX
LINDQVIST B
GAROFF H
VONBONSDORFF CH
LILJESTROM P
Citation: Hx. Zhao et al., A TYROSINE-BASED MOTIF IN THE CYTOPLASMIC DOMAIN OF THE ALPHAVIRUS ENVELOPE PROTEIN IS ESSENTIAL FOR BUDDING, EMBO journal, 13(18), 1994, pp. 4204-4211
Citation: Gm. Glasgow et al., A SINGLE AMINO-ACID CHANGE IN THE E2 SPIKE PROTEIN OF A VIRULENT-STRAIN OF SEMLIKI-FOREST VIRUS ATTENUATES PATHOGENICITY, Journal of General Virology, 75, 1994, pp. 663-668
Authors:
LUNDSTROM K
MILLS A
BUELL G
ALLET E
ADAMI N
LILJESTROM P
Citation: K. Lundstrom et al., HIGH-LEVEL EXPRESSION OF THE HUMAN NEUROKININ-1 RECEPTOR IN MAMMALIAN-CELL LINES USING THE SEMLIKI FOREST VIRUS EXPRESSION SYSTEM, European journal of biochemistry, 224(3), 1994, pp. 917-921
Authors:
PAUL NL
MARSH M
MCKEATING JA
SCHULZ TF
LILJESTROM P
GAROFF H
WEISS RA
Citation: Nl. Paul et al., EXPRESSION OF HIV-1 ENVELOPE GLYCOPROTEINS BY SEMLIKI FOREST VIRUS VECTORS, AIDS research and human retroviruses, 9(10), 1993, pp. 963-970
Authors:
BERGLUND P
SJOBERG M
GAROFF H
ATKINS GJ
SHEAHAN BJ
LILJESTROM P
Citation: P. Berglund et al., SEMLIKI FOREST VIRUS EXPRESSION SYSTEM - PRODUCTION OF CONDITIONALLY INFECTIOUS RECOMBINANT PARTICLES, Bio/technology, 11(8), 1993, pp. 916-920
Authors:
OLKKONEN VM
LILJESTROM P
GAROFF H
SIMONS K
DOTTI CG
Citation: Vm. Olkkonen et al., EXPRESSION OF HETEROLOGOUS PROTEINS IN CULTURED RAT HIPPOCAMPAL-NEURONS USING THE SEMLIKI FOREST VIRUS VECTOR, Journal of neuroscience research, 35(4), 1993, pp. 445-451
Citation: P. Mikus et al., IS PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 (PAI-2) SECRETED IN A TISSUE-SPECIFIC MANNER, Thrombosis and haemostasis, 69(6), 1993, pp. 1329-1329